Lupin to market Visus' presbyopia drug in Europe, UK

Lupin Limited on Thursday (20) announced that its Europe-based ophthalmology-focused subsidiary VISUfarma BV has entered into a licensing agreement with US-based Visus Therapeutics Inc, to market its eye drops Yuvezzi in Europe. VISUfarma will enjoy exclusive rights to undertake regulatory activities, commercialization, marketing, promotion, distribution and sale of Yuvezzi, an eye drop to treat…